Gokhale NS |
Systematic approach to managing vernal keratoconjunctivitis in clinical practice: Severity grading system and a treatment algorithm. |
2016 |
Indian J Ophthalmol |
pmid:27050351
|
Rotenstein L et al. |
Management of refractory autoimmune hemolytic anemia via allogeneic stem cell transplantation. |
2016 |
Bone Marrow Transplant. |
pmid:27272445
|
Wen Y et al. |
Tacrolimus restores podocyte injury and stabilizes the expression of Cabin1 in 5/6 nephrectomized rats. |
2016 |
Ren Fail |
pmid:26905810
|
Törlén J et al. |
A prospective randomized trial comparing cyclosporine/methotrexate and tacrolimus/sirolimus as graft-versus-host disease prophylaxis after allogeneic hematopoietic stem cell transplantation. |
2016 |
Haematologica |
pmid:27662016
|
Martial LC et al. |
A preliminary study searching for the right dose of tacrolimus in very young (≤4 years) renal transplant patients. |
2016 |
J. Pharm. Pharmacol. |
pmid:27669677
|
Chang KT et al. |
Tacrolimus suppresses atopic dermatitis-associated cytokines and chemokines in monocytes. |
2016 |
J Microbiol Immunol Infect |
pmid:25315214
|
Zeng W et al. |
Hyaluronic acid-coated niosomes facilitate tacrolimus ocular delivery: Mucoadhesion, precorneal retention, aqueous humor pharmacokinetics, and transcorneal permeability. |
2016 |
Colloids Surf B Biointerfaces |
pmid:26820107
|
Nuki Y et al. |
Comparison of the therapeutic efficacy and safety between tacrolimus and infliximab for moderate-to-severe ulcerative colitis: a single center experience. |
2016 |
Scand. J. Gastroenterol. |
pmid:26818468
|
Joko T et al. |
Therapeutic Effect of 0.1% Topical Tacrolimus for Childhood Interstitial Keratitis Refractory to Cyclosporine. |
2016 |
J Nippon Med Sch |
pmid:26960587
|
Malachowski SJ et al. |
Annular Lichenoid Dermatitis of Youth: A Chronic Case Managed Using Pimecrolimus. |
2016 |
Pediatr Dermatol |
pmid:27653808
|
Sawada T et al. |
Experimental Studies on Protective Effects of FK506 Against Hepatic Ischemia-Reperfusion Injury. |
2016 |
J. Med. Invest. |
pmid:27644569
|
Chen CA et al. |
Quantitative analysis of tissue inflammation and responses to treatment in immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome, and review of literature. |
2016 |
J Microbiol Immunol Infect |
pmid:26748735
|
Yoshida T et al. |
Oral tacrolimus oil formulations for enhanced lymphatic delivery and efficient inhibition of T-cell's interleukin-2 production. |
2016 |
Eur J Pharm Biopharm |
pmid:26748381
|
Radziejewski K and Balicki I |
Comparative clinical evaluation of tacrolimus and cyclosporine eye drops for the treatment of canine keratoconjunctivitis sicca. |
2016 |
Acta Vet. Hung. |
pmid:27653428
|
Kannegieter NM et al. |
Conversion to Once-Daily Tacrolimus Results in Increased p38MAPK Phosphorylation in T Lymphocytes of Kidney Transplant Recipients. |
2016 |
Ther Drug Monit |
pmid:26606072
|
Wang Z et al. |
Nanocomposite microparticles (nCmP) for the delivery of tacrolimus in the treatment of pulmonary arterial hypertension. |
2016 |
Int J Pharm |
pmid:27568494
|
Rahnama-Moghadam S et al. |
Vesicular eruption in a 2-year-old boy. |
2016 |
J Fam Pract |
pmid:27565104
|
Lee C et al. |
Treatment of bleomycin-induced pulmonary fibrosis by inhaled tacrolimus-loaded chitosan-coated poly(lactic-co-glycolic acid) nanoparticles. |
2016 |
Biomed. Pharmacother. |
pmid:26898446
|
Cassuto E et al. |
Adherence to and Acceptance of Once-Daily Tacrolimus After Kidney and Liver Transplant: Results From OSIRIS, a French Observational Study. |
2016 |
Transplantation |
pmid:27653227
|
Zegarska J et al. |
Tacrolimus Metabolite M-III May Have Nephrotoxic and Myelotoxic Effects and Increase the Incidence of Infections in Kidney Transplant Recipients. |
2016 |
Transplant. Proc. |
pmid:27496443
|
Bargnoux AS et al. |
Evaluation of the New Siemens Tacrolimus Assay on the Dimension EXL Integrated Chemistry System Analyzer: Comparison With an Ultra-Performance Liquid Chromatography-Tandem Mass Spectrometry Method. |
2016 |
Ther Drug Monit |
pmid:27494947
|
Zmonarski SC et al. |
Lowering of Messenger Ribonucleic Acid Toll-Like Receptors 2-4,9 in Peripheral Blood Mononuclear Cells in Kidney Allograft Recipients, Relationships With Immunosuppressive Treatment, and Delayed Graft Function Occurrence. |
2016 |
Transplant. Proc. |
pmid:27496439
|
Ashizuka S et al. |
Adrenomedullin Therapy in Patients with Refractory Ulcerative Colitis: A Case Series. |
2016 |
Dig. Dis. Sci. |
pmid:26470867
|
Matsui K et al. |
Betamethasone, but Not Tacrolimus, Suppresses the Development of Th2 Cells Mediated by Langerhans Cell-Like Dendritic Cells. |
2016 |
Biol. Pharm. Bull. |
pmid:27374298
|
Kimsa M et al. |
Transforming growth factor β-related genes in human retinal pigment epithelial cells after tacrolimus treatment. |
2016 |
Pharmacol Rep |
pmid:27372923
|
GarcÃa-Delgado R et al. |
Systemic Absorption of Topical Tacrolimus in Metastatic Crohn Disease With Skin Ulcers. |
2016 |
Actas Dermosifiliogr |
pmid:27372545
|
Vignali D et al. |
IL-7 Mediated Homeostatic Expansion of Human CD4+CD25+FOXP3+ Regulatory T Cells After Depletion With Anti-CD25 Monoclonal Antibody. |
2016 |
Transplantation |
pmid:27306531
|
Saitman A et al. |
Evaluation of the Waters MassTrak LC-MS/MS Assay for Tacrolimus and a Comparison to the Abbott Architect Immunoassay. |
2016 |
Ther Drug Monit |
pmid:26473523
|
Tanzi MG et al. |
Pharmacokinetics of prolonged-release tacrolimus and implications for use in solid organ transplant recipients. |
2016 |
Clin Transplant |
pmid:27220013
|
Yamashita T et al. |
Effects of CYP3A5 polymorphism on the pharmacokinetics of a once-daily modified-release tacrolimus formulation and acute kidney injury in hematopoietic stem cell transplantation. |
2016 |
Cancer Chemother. Pharmacol. |
pmid:27217047
|
Tremblay S et al. |
Absence of the Effect of Pretransplant Body Mass Index on Post Kidney Transplant Outcomes. |
2016 |
Prog Transplant |
pmid:27207408
|
Emoto C et al. |
Risk Assessment of Drug-Drug Interactions of Calcineurin Inhibitors Affecting Sirolimus Pharmacokinetics in Renal Transplant Patients. |
2016 |
Ther Drug Monit |
pmid:27310200
|
Badri PS et al. |
Pharmacokinetics of Tacrolimus and Cyclosporine in Liver Transplant Recipients Receiving 3 Direct-Acting Antivirals as Treatment for Hepatitis C Infection. |
2016 |
Ther Drug Monit |
pmid:27310199
|
RodrÃguez-AusÃn P et al. |
Topical tacrolimus 0.03% for the treatment of ocular psoriasis. |
2016 |
Arch Soc Esp Oftalmol |
pmid:27130870
|
Stifft F et al. |
Effect of Breakfast on the Exposure of the Once-Daily Tacrolimus Formulation in Stable Kidney Transplant Recipients. |
2016 |
Ther Drug Monit |
pmid:27128604
|
Pirmez R et al. |
Acne keloidalis nuchae in renal transplant patients receiving tacrolimus and sirolimus. |
2016 |
Australas. J. Dermatol. |
pmid:27124649
|
Khaled SK et al. |
Influence of Absorption, Distribution, Metabolism, and Excretion Genomic Variants on Tacrolimus/Sirolimus Blood Levels and Graft-versus-Host Disease after Allogeneic Hematopoietic Cell Transplantation. |
2016 |
Biol. Blood Marrow Transplant. |
pmid:26325438
|
Lee DR et al. |
Enhanced dissolution and oral absorption of tacrolimus by supersaturable self-emulsifying drug delivery system. |
2016 |
Int J Nanomedicine |
pmid:27051286
|
Cai SC et al. |
Topical calcineurin inhibitors in eczema and cancer association: A cohort study. |
2016 |
J Dermatolog Treat |
pmid:27049893
|
Traitanon O et al. |
Differential Effects of Tacrolimus versus Sirolimus on the Proliferation, Activation and Differentiation of Human B Cells. |
2015 |
PLoS ONE |
pmid:26087255
|
Wang X et al. |
Tacrolimus 0.03% ointment in labial discoid lupus erythematosus: A randomized, controlled clinical trial. |
2015 |
J Clin Pharmacol |
pmid:25951426
|
Størset E et al. |
Improved Tacrolimus Target Concentration Achievement Using Computerized Dosing in Renal Transplant Recipients--A Prospective, Randomized Study. |
2015 |
Transplantation |
pmid:25886918
|
Soylu H et al. |
Survival of renal transplant patients: data from a tertiary care center in Turkey. |
2015 |
Transplant. Proc. |
pmid:25769571
|
Ohe M and Bohgaki T |
A Case of Adult-Onset Still's Disease Treated with Monitoring of Serum Tacrolimus Levels. |
2015 |
Bull Hosp Jt Dis (2013) |
pmid:26535602
|
Abdel-Azim H et al. |
Unrelated donor hematopoietic stem cell transplantation for the treatment of non-malignant genetic diseases: An alemtuzumab based regimen is associated with cure of clinical disease; earlier clearance of alemtuzumab may be associated with graft rejection. |
2015 |
Am. J. Hematol. |
pmid:26242764
|
Liu X et al. |
Associations of HSD11B1 polymorphisms with tacrolimus concentrations in Chinese renal transplant recipients with prednisone combined therapy. |
2015 |
Drug Metab. Dispos. |
pmid:25587129
|
Roche NA et al. |
Long-Term Multifunctional Outcome and Risks of Face Vascularized Composite Allotransplantation. |
2015 |
J Craniofac Surg |
pmid:26468783
|
Ogul H et al. |
Severe toxic leukoencephalopathy associated with tacrolimus after living donor liver transplantation. |
2015 |
Acta Neurol Belg |
pmid:24854146
|
Krystel-Whittemore M et al. |
Polyomavirus nephropathy of the native kidney in a patient with rheumatoid arthritis and pulmonary fibrosis. |
2015 |
BMJ Case Rep |
pmid:26318171
|
Vives R et al. |
Safety and Activity of UR-1505 in Atopic Dermatitis: A Randomized, Double-blind Phase II Exploratory Trial. |
2015 |
Clin Ther |
pmid:26163200
|